Can't cancer patients eat Ganoderma lucidum

summary

Cancer, also known as "malignant tumor", has been threatening human life for a long time. With the rapid rise of incidence rate of cancer, people are increasingly concerned about how cancer causes. What are the therapeutic methods for cancer? Can cancer patients eat Ganoderma lucidum? What are the therapeutic effects of Ganoderma lucidum on cancer?

Can't cancer patients eat Ganoderma lucidum

Ganoderma lucidum (polysaccharide) can enhance the functions of various immune cells, such as killing tumor cells by enhancing the functions of dendritic cells, macrophages, natural killer cells (NK), B cells and T cells, or promoting the secretion of cytokines by immune cells, inhibiting tumor cells or promoting their apoptosis. The anti-tumor mechanism of Ganoderma lucidum polysaccharides is endogenous and realized by the immune system. In particular, T cells and natural killer cells play a key role in controlling the recurrence and metastasis of cancer. The intervention of Ganoderma lucidum will increase a lot of chips for patients to successfully fight cancer.

Ganoderma lucidum (triterpenoids) can directly inhibit the growth of tumor cells: different from the endogenous anti-tumor mechanism of Ganoderma lucidum polysaccharide enhancing immune function, the triterpenoids contained in Ganoderma lucidum can directly inhibit the proliferation, invasion, metastasis and induce apoptosis of tumor cells cultured in vitro, and block the migration from G1 phase to S phase in cell cycle. Its mechanism of action is similar to that of some chemotherapy drugs or targeted drugs It has similarity, but no side effects.

Ganoderma lucidum inhibits tumor angiogenesis: the growth of solid tumor completely depends on its own blood supply. If there are no new capillaries in the tumor with diameter > 2mm, the tumor tissue will remain dormant or degenerate, with little metastasis. Pharmacological studies have confirmed that Ganoderma lucidum (polysaccharides and triterpenoids) can inhibit tumor angiogenesis by inhibiting the proliferation of vascular endothelial cells. If tumor cells lack blood supply and nutrition, their growth will be inhibited or even apoptosis.

matters needing attention

Summarizing the pharmacological research results of Ganoderma lucidum for more than 40 years, we can find that the anti-tumor mechanism of Ganoderma lucidum is diversified and multi-target, but it does not mean that Ganoderma lucidum can replace the mainstream treatment. Although the multiple mechanisms of action of Ganoderma lucidum are effective and safe, they are not as strong as the single use of surgery, radiotherapy and chemotherapy. It also shows that the tumor that has grown to a large size may exceed the regulatory capacity of Ganoderma lucidum alone. However, if Ganoderma lucidum is used as a kind of cancer synergistic therapy, it is really the most appropriate drug. However, it can improve the therapeutic effect of cancer to a considerable extent, reduce the risk of recurrence and metastasis, and even prolong the survival period, which also answers the question of what cancer patients should eat. With the deepening of Ganoderma lucidum theoretical research and the accumulation of human clinical experience, highly concentrated Ganoderma lucidum preparation can become the most basic anti-cancer drug besides the mainstream treatment.